Current and Future Imaging Paradigms in Colorectal Cancer

Seminars in Colon and Rectal Surgery

Volumn 18, Issue 2, 2007, Pages 132-138

  Mahmood, Umar ^a   Upadhyay, Rabi ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTRAN SULFATE; IRON OXIDE; NANOPARTICLE; SMALL PARTICLE IRON OXIDE; SUPERPARAMAGNETIC IRON OXIDE; ULTRASMALL PARTICLE IRON OXIDE; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; UNCLASSIFIED DRUG;

ARTICLE; COLORECTAL CANCER; COLORECTAL SURGERY; ENDOSCOPY; EVALUATION; FLUORESCENCE; HUMAN; IMAGE ENHANCEMENT; LYMPH NODE METASTASIS; MECHANICAL PROBE; MOLECULAR IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY;

EID: 34249295194     PISSN: 10431489     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.scrs.2007.03.007     Document Type: Article

References (48)

1. Weissleder R., and Mahmood U. Molecular imaging. Radiology 219 (2001) 316-333
2. Wolff W.I. Colonoscopy: history and development. Am J Gastroenterol 84 (1989) 1017-1025
3. Lux G., Knyrim K., Scheubel R., and Classen M. Electronic endoscopy-fibres or chips?. Z Gastroenterol 24 (1986) 337-343
4. Barclay R.L., Vicari J.J., Doughty A.S., et al. Colonoscopic withdrawal times and adenoma detection during screening colonoscopy. N Engl J Med 355 (2006) 2533-2541
5. Schoofs N., Deviere J., and Van Gossum A. PillCam colon capsule endoscopy compared with colonoscopy for colorectal tumor diagnosis: a prospective pilot study. Endoscopy 38 (2006) 971-977
6. Francis I.R., Cohan R.H., McNulty N.J., et al. Multidetector CT of the liver and hepatic neoplasms: effect of multiphasic imaging on tumor conspicuity and vascular enhancement. AJR Am J Roentgenol 180 (2003) 1217-1224
7. Klessen C., Rogalla P., and Taupitz M. Local staging of rectal cancer: the current role of MRI. Eur Radiol 17 (2007) 379-389
8. Kim C.K., Kim S.H., Chun H.K., et al. Preoperative staging of rectal cancer: accuracy of 3-Tesla magnetic resonance imaging. Eur Radiol 16 (2006) 972-980
9. Pickhardt P.J., Choi J.R., Hwang I., et al. Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults. N Engl J Med 349 (2003) 2191-2200
10. von Schulthess G.K., Steinert H.C., and Hany T.F. Integrated PET/CT: current applications and future directions. Radiology 238 (2006) 405-422
11. Gambhir S.S. Molecular imaging of cancer with positron emission tomography. Nat Rev Cancer 2 (2002) 683-693
12. Chen Y.K., Kao C.H., Liao A.C., et al. Colorectal cancer screening in asymptomatic adults: the role of FDG PET scan. Anticancer Res 23 (2003) 4357-4361
13. Veit-Haibach P., Kuehle C.A., Beyer T., et al. Diagnostic accuracy of colorectal cancer staging with whole-body PET/CT colonography. JAMA 296 (2006) 2590-2600
14. Berger K.L., Nicholson S.A., Dehdashti F., et al. FDG PET evaluation of mucinous neoplasms: correlation of FDG uptake with histopathologic features. AJR Am J Roentgenol 174 (2000) 1005-1008
15. Whiteford MH, Whiteford HM, Yee LF, et al: Usefulness of FDG-PET scan in the assessment of suspected metastatic or recurrent adenocarcinoma of the colon and rectum. Dis Colon Rectum 43:759-767; discussion 767-770, 2000
16. Jager G.J., Barentsz J.O., Oosterhof G.O., et al. Pelvic adenopathy in prostatic and urinary bladder carcinoma: MR imaging with a three-dimensional TI-weighted magnetization-prepared-rapid gradient-echo sequence. AJR Am J Roentgenol 167 (1996) 1503-1507
17. Kim J.H., Beets G.L., Kim M.J., et al. High-resolution MR imaging for nodal staging in rectal cancer: are there any criteria in addition to the size?. Eur J Radiol 52 (2004) 78-83
18. Bulte J.W., Arbab A.S., Douglas T., et al. Preparation of magnetically labeled cells for cell tracking by magnetic resonance imaging. Methods Enzymol 386 (2004) 275-299
19. Weissleder R., Elizondo G., Wittenberg J., et al. Ultrasmall superparamagnetic iron oxide: an intravenous contrast agent for assessing lymph nodes with MR imaging. Radiology 175 (1990) 494-498
20. Weissleder R., Elizondo G., Wittenberg J., et al. Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging. Radiology 175 (1990) 489-493
21. Harisinghani M.G., Saini S., Slater G.J., et al. MR imaging of pelvic lymph nodes in primary pelvic carcinoma with ultrasmall superparamagnetic iron oxide (Combidex): preliminary observations. J Magn Reson Imaging 7 (1997) 161-163
22. Saksena M.A., Saokar A., and Harisinghani M.G. Lymphotropic nanoparticle enhanced MR imaging (LNMRI) technique for lymph node imaging. Eur J Radiol 58 (2006) 367-374
23. Harisinghani M.G., Barentsz J., Hahn P.F., et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 348 (2003) 2491-2499
24. Boxerman J.L., Hamberg L.M., Rosen B.R., et al. MR contrast due to intravascular magnetic susceptibility perturbations. Magn Reson Med 34 (1995) 555-566
25. Chen H.X., Mooney M., Boron M., et al. Phase II multicenter trial of bevacizumab plus fluorouracil and leucovorin in patients with advanced refractory colorectal cancer: an NCI Treatment Referral Center Trial TRC-0301. J Clin Oncol 24 (2006) 3354-3360
26. Kim Y.R., Yudina A., Figueiredo J., et al. Detection of early antiangiogenic effects in human colon adenocarcinoma xenografts: in vivo changes of tumor blood volume in response to experimental VEGFR tyrosine kinase inhibitor. Cancer Res 65 (2005) 9253-9260
27. van Rijn J.C., Reitsma J.B., Stoker J., et al. Polyp miss rate determined by tandem colonoscopy: a systematic review. Am J Gastroenterol 101 (2006) 343-350
28. Rembacken B.J., Fujii T., Cairns A., et al. Flat and depressed colonic neoplasms: a prospective study of 1000 colonoscopies in the UK. Lancet 355 (2000) 1211-1214
29. Kiesslich R., Fritsch J., Holtmann M., et al. Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. Gastroenterology 124 (2003) 880-888
30. Bernstein C.N., Weinstein W.M., Levine D.S., et al. Physicians' perceptions of dysplasia and approaches to surveillance colonoscopy in ulcerative colitis. Am J Gastroenterol 90 (1995) 2106-2114
31. Desai N.D., Miwa S., Kodama D., et al. Improving the quality of coronary bypass surgery with intraoperative angiography: validation of a new technique. J Am Coll Cardiol 46 (2005) 1521-1525
32. Funovics M.A., Weissleder R., and Mahmood U. Catheter-based in vivo imaging of enzyme activity and gene expression: feasibility study in mice. Radiology 231 (2004) 659-666
33. Weissleder R., Tung C.H., Mahmood U., et al. In vivo imaging of tumors with protease-activated near-infrared fluorescent probes. Nat Biotechnol 17 (1999) 375-378
34. Nomura T., and Katunuma N. Involvement of cathepsins in the invasion, metastasis and proliferation of cancer cells. J Med Invest 52 (2005) 1-9
35. Bremer C., Tung C.H., and Weissleder R. In vivo molecular target assessment of matrix metalloproteinase inhibition. Nat Med 7 (2001) 743-748
36. Tung C.H., Mahmood U., Bredow S., et al. In vivo imaging of proteolytic enzyme activity using a novel molecular reporter. Cancer Res 60 (2000) 4953-4958
37. Figueiredo J.L., Alencar H., Weissleder R., et al. Near infrared thoracoscopy of tumoral protease activity for improved detection of peripheral lung cancer. Int J Cancer 118 (2006) 2672-2677
38. Marten K., Bremer C., Khazaie K., et al. Detection of dysplastic intestinal adenomas using enzyme-sensing molecular beacons in mice. Gastroenterology 122 (2002) 406-414
39. Funovics M.A., Alencar H., Su H.S., et al. Miniaturized multichannel near infrared endoscope for mouse imaging. Mol Imaging 2 (2003) 350-357
40. Mahmood U., Tung C.H., Tang Y., et al. Feasibility of in vivo multichannel optical imaging of gene expression: experimental study in mice. Radiology 224 (2002) 446-451
41. Montet X., Ntziachristos V., Grimm J., et al. Tomographic fluorescence mapping of tumor targets. Cancer Res 65 (2005) 6330-6336
42. Hurwitz H., Fehrenbacher L., Novotny W., et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350 (2004) 2335-2342
43. Achilefu S., Jimenez H.N., Dorshow R.B., et al. Synthesis, in vitro receptor binding, and in vivo evaluation of fluorescein and carbocyanine peptide-based optical contrast agents. J Med Chem 45 (2002) 2003-2015
44. Licha K., Hessenius C., Becker A., et al. Synthesis, characterization, and biological properties of cyanine-labeled somatostatin analogues as receptor-targeted fluorescent probes. Bioconjug Chem 12 (2001) 44-50
45. Kelly K., Alencar H., Funovics M., et al. Detection of invasive colon cancer using a novel, targeted, library-derived fluorescent peptide. Cancer Res 64 (2004) 6247-6251
46. Montet X., Montet-Abou K., Reynolds F., et al. Nanoparticle imaging of integrins on tumor cells. Neoplasia 8 (2006) 214-222
47. Chen W.T., Khazaie K., Zhang G., et al. Detection of dysplastic intestinal adenomas using a fluorescent folate imaging probe. Mol Imaging 4 (2005) 67-74
48. Kennedy M.D., Jallad K.N., Thompson D.H., et al. Optical imaging of metastatic tumors using a folate-targeted fluorescent probe. J Biomed Opt 8 (2003) 636-641